Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Healthpeak Properties, Inc. DOC

Set alert

Price alert · DOC

All alert types
19.03 USD +0.09 +0.48%

At close

19.37 +0.34 +1.79%

Pre-market · Nov 2, 6:07 AM ET

Bid
19.03 × 5,300
Ask
19.05 × 2,900
18.89 Day range 19.16
15.70 52-week range 22.95
YTD
+18.35%
1 year
+8.31%
Open
19.04
Prev close
18.94
Mkt cap
13.49B
Vol
6.41M
Avg vol
5.39M
EPS
0.36
P/E
52.86
Div yield
6.44%
More statistics
Low
18.89
High
19.16
Forward P/E
136.14
Beta
0.99
Short ratio
3.52
Inst. own
97.82%
Dividend
1.22
Ex-div date
Nov 12, 2026
Earnings
Nov 2, 2026
50-d avg
19.95
200-d avg
19.12
1y target
22.39

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 5, 2026Earnings: 0.28; estimate 0.05276; surprise 430.71%
  • May 18, 2026Dividend: 0.10167
  • Jun 15, 2026Dividend: 0.10167
  • Jul 20, 2026Dividend: 0.10167
  • Aug 4, 2026Earnings: 0.08; estimate 0.02815; surprise 184.19%
  • Aug 13, 2026Rating: Baird · Outperform → Outperform
  • Aug 17, 2026Dividend: 0.10167
  • Aug 31, 2026Rating: Barclays · Equal-Weight → Equal-Weight
  • Sep 14, 2026Dividend: 0.10167
  • Sep 21, 2026Rating: Evercore ISI Group · In-Line → In-Line
  • Oct 13, 2026Rating: Barclays · Equal-Weight → Equal-Weight
  • Oct 13, 2026Rating: UBS · Neutral → Neutral
  • Oct 19, 2026Dividend: 0.10167
  • Oct 19, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
Signals (37)
NameDateAgo
MACD: Buy SignalOct 20, 20261 week ago
MACD: Sell SignalOct 19, 20261 week ago
MACD: Buy SignalOct 16, 20262 weeks ago
RSI: OversoldOct 5, 20263 weeks ago
RSI: OversoldOct 1, 20261 month ago
MACD: Sell SignalSep 28, 20261 month ago
SMA: BearishSep 22, 20261 month ago
SMA: BullishSep 21, 20261 month ago
MACD: Buy SignalSep 21, 20261 month ago
SMA: BearishSep 18, 20261 month ago
SMA: BullishSep 17, 20261 month ago
SMA: BearishSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BearishSep 11, 20261 month ago
MACD: Sell SignalSep 1, 20262 months ago
SMA: BearishAug 27, 20262 months ago
MACD: Buy SignalAug 24, 20262 months ago
SMA: BullishAug 21, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 7, 20262 months ago
SMA: BearishAug 6, 20262 months ago
MACD: Sell SignalJul 22, 20263 months ago
MACD: Buy SignalJul 21, 20263 months ago
MACD: Sell SignalJul 20, 20263 months ago
MACD: Buy SignalJul 17, 20263 months ago
RSI: OverboughtJul 17, 20263 months ago
MACD: Sell SignalJul 10, 20263 months ago
RSI: OverboughtJun 29, 20264 months ago
MACD: Buy SignalJun 25, 20264 months ago
MACD: Sell SignalJun 16, 20264 months ago
MACD: Buy SignalJun 10, 20264 months ago
MACD: Sell SignalMay 28, 20265 months ago
RSI: OverboughtMay 20, 20265 months ago
SMA: BullishMay 6, 20265 months ago
SMA: BullishMay 6, 20265 months ago
MACD: Buy SignalMay 6, 20265 months ago
RSI: OverboughtMay 6, 20265 months ago

Financial health

Altman Z-Score

0.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 2
  • Return on Assets 2
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E 161×
FY 2016: 22.2×FY 2017: 29.6×FY 2018: 12.4×FY 2019: 383×FY 2020: 39.3×FY 2021: 38.8×FY 2022: 27.3×FY 2023: 35.4×FY 2024: 56.3×FY 2025: 161×
FY 2016 5y median 38.8× FY 2025
P/S 4.0×
FY 2016: 6.5×FY 2017: 6.6×FY 2018: 11.0×FY 2019: 13.5×FY 2020: 9.8×FY 2021: 10.3×FY 2022: 6.6×FY 2023: 5.0×FY 2024: 5.1×FY 2025: 4.0×
FY 2016 5y median 5.1× FY 2025
P/B 1.5×
FY 2016: 8.0×FY 2017: 4.9×FY 2018: 5.5×FY 2019: 2.8×FY 2020: 2.4×FY 2021: 3.0×FY 2022: 2.0×FY 2023: 1.7×FY 2024: 1.6×FY 2025: 1.5×
FY 2016 5y median 1.7× FY 2025
P/FCF 8.9×
FY 2016: 11.4×FY 2017: 14.4×FY 2018: 15.5×FY 2019: 19.8×FY 2020: 21.1×FY 2021: 24.5×FY 2022: 15.0×FY 2023: 11.3×FY 2024: 12.8×FY 2025: 8.9×
FY 2016 5y median 12.8× FY 2025
EV/EBITDA 14.7×
FY 2016: 10.6×FY 2017: 10.9×FY 2018: 8.9×FY 2019: 21.7×FY 2020: 19.8×FY 2021: 26.4×FY 2022: 14.5×FY 2023: 14.1×FY 2024: 14.0×FY 2025: 14.7×
FY 2016 5y median 14.5× FY 2025
EV/Sales 7.5×
FY 2016: 7.0×FY 2017: 7.4×FY 2018: 12.3×FY 2019: 18.4×FY 2020: 13.7×FY 2021: 13.5×FY 2022: 9.8×FY 2023: 8.2×FY 2024: 8.4×FY 2025: 7.5×
FY 2016 5y median 8.4× FY 2025
FCF Yield 11.2%
FY 2016: 8.7%FY 2017: 6.9%FY 2018: 6.5%FY 2019: 5.0%FY 2020: 4.7%FY 2021: 4.1%FY 2022: 6.7%FY 2023: 8.8%FY 2024: 7.8%FY 2025: 11.2%
FY 2016 5y median 7.8% FY 2025

Profitability

Gross Margin 22.5%
FY 2016: 65.3%FY 2017: 64.0%FY 2018: 68.2%FY 2019: 67.3%FY 2020: 52.4%FY 2021: 59.2%FY 2022: 58.1%FY 2023: 58.6%FY 2024: 60.2%FY 2025: 22.5%
FY 2016 5y median 58.6% FY 2025
Operating Margin 19.3%
FY 2016: 33.8%FY 2017: 30.2%FY 2018: 26.1%FY 2019: 24.7%FY 2020: 13.1%FY 2021: 17.9%FY 2022: 17.3%FY 2023: 19.9%FY 2024: 17.4%FY 2025: 19.3%
FY 2016 5y median 17.9% FY 2025
Net Margin 2.5%
FY 2016: 29.5%FY 2017: 22.4%FY 2018: 89.1%FY 2019: 3.7%FY 2020: 25.1%FY 2021: 26.7%FY 2022: 24.3%FY 2023: 14.0%FY 2024: 9.0%FY 2025: 2.5%
FY 2016 5y median 14.0% FY 2025
ROE 1.0%
FY 2016: 36.1%FY 2017: 16.7%FY 2018: 44.6%FY 2019: 0.7%FY 2020: 6.1%FY 2021: 7.8%FY 2022: 7.5%FY 2023: 4.8%FY 2024: 2.9%FY 2025: 1.0%
FY 2016 5y median 4.8% FY 2025
ROIC 37.3%
FY 2016: 31.5%FY 2017: 15.0%FY 2018: 8.7%FY 2019: 2.3%FY 2020: 1.5%FY 2021: 2.3%FY 2022: 2.4%FY 2023: 2.9%FY 2024: 2.4%FY 2025: 37.3%
FY 2016 5y median 2.4% FY 2025
ROA 0.4%
FY 2016: 21.7%FY 2017: 9.9%FY 2018: 25.6%FY 2019: 0.3%FY 2020: 2.6%FY 2021: 3.3%FY 2022: 3.2%FY 2023: 1.9%FY 2024: 1.2%FY 2025: 0.4%
FY 2016 5y median 1.9% FY 2025

Growth (YoY)

Revenue 4.5%
FY 2016: 9.7%FY 2017: -13.2%FY 2018: -35.5%FY 2019: 4.1%FY 2020: 32.6%FY 2021: 15.3%FY 2022: 8.7%FY 2023: 5.8%FY 2024: 23.8%FY 2025: 4.5%
FY 2016 FY 2025
Operating Income 15.5%
FY 2016: -1.3%FY 2017: -22.3%FY 2018: -44.3%FY 2019: -1.4%FY 2020: -29.9%FY 2021: 58.2%FY 2022: 4.8%FY 2023: 21.7%FY 2024: 8.6%FY 2025: 15.5%
FY 2016 FY 2025
EPS (diluted) -72.2%
FY 2016: 210.7%FY 2017: -34.3%FY 2018: 154.5%FY 2019: -96.0%FY 2020: 755.6%FY 2021: 20.8%FY 2022: -1.1%FY 2023: -39.1%FY 2024: -35.7%FY 2025: -72.2%
FY 2016 FY 2025
Free Cash Flow 17.0%
FY 2016: -0.7%FY 2017: -30.2%FY 2018: 0.2%FY 2019: -0.3%FY 2020: -10.4%FY 2021: 4.9%FY 2022: 13.2%FY 2023: 6.2%FY 2024: 11.9%FY 2025: 17.0%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 4.2×FY 2020: 2.3×FY 2021: 0.4×FY 2022: 0.3×FY 2023: 0.4×FY 2024: 1.1×FY 2025: 1.1×
FY 2016 5y median 0.4× FY 2025
Quick Ratio 1.1×
FY 2016: 0.1×FY 2017: 0.3×FY 2018: 0.2×FY 2019: 4.2×FY 2020: 2.3×FY 2021: 0.4×FY 2022: 0.3×FY 2023: 0.4×FY 2024: 1.1×FY 2025: 1.1×
FY 2016 5y median 0.4× FY 2025
Debt / Equity 1.4×
FY 2016: 0.6×FY 2017: 0.6×FY 2018: 0.6×FY 2019: 1.0×FY 2020: 1.0×FY 2021: 1.0×FY 2022: 1.0×FY 2023: 1.1×FY 2024: 1.1×FY 2025: 1.4×
FY 2016 5y median 1.1× FY 2025
Net Debt / EBITDA 6.9×
FY 2016: 0.7×FY 2017: 1.2×FY 2018: 0.9×FY 2019: 5.8×FY 2020: 5.7×FY 2021: 6.4×FY 2022: 4.8×FY 2023: 5.5×FY 2024: 5.5×FY 2025: 6.9×
FY 2016 5y median 5.5× FY 2025
Interest Coverage 1.8×
FY 2016: 1.5×FY 2017: 1.8×FY 2018: 1.2×FY 2019: 1.4×FY 2020: 1.0×FY 2021: 2.2×FY 2022: 2.1×FY 2023: 2.2×FY 2024: 1.7×FY 2025: 1.8×
FY 2016 5y median 2.1× FY 2025

Dividends

Dividend Yield 7.6%
FY 2016: 7.1%FY 2017: 5.7%FY 2018: 5.3%FY 2019: 4.3%FY 2020: 4.9%FY 2021: 3.3%FY 2022: 4.8%FY 2023: 6.1%FY 2024: 5.8%FY 2025: 7.6%
FY 2016 5y median 5.8% FY 2025
Payout Ratio 1190.1%
FY 2016: 156.0%FY 2017: 167.8%FY 2018: 65.7%FY 2019: 1581.6%FY 2020: 190.3%FY 2021: 128.6%FY 2022: 129.5%FY 2023: 214.7%FY 2024: 326.9%FY 2025: 1190.1%
FY 2016 5y median 214.7% FY 2025

Annual · latest fiscal year ends 2025-12-31